STEPHEN HILL

Profile

First Name

: STEPHEN

Middle Name

:

Last Name

: HILL

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

SHEER WIND, INC.

DARYOUSH ALLAEI, MARK P BORMAN, RUSS BRUEMMER, HERBERT CONNOR, JOSEPH C LAWYER, CYNTHIA LESHER, CYNTHIA L LESHER, JAY A NOVAK, RICHIE LEE TABACHNICK

EXECUTIVE OFFICER, DIRECTOR

FARADAY PHARMACEUTICALS, INC.

BRIAN BLACKMAN, STEVEN GILLIS, LAWRENCE GOZLAN, PAULINA HILL, RONALD KIERPA, THOMAS KING, TERRANCE MCGUIRE, ROBERT NELSEN, PATRICK ROCK, MARK ROTH, SIMON TULLOCH

EXECUTIVE OFFICER

LYELL IMMUNOPHARMA, INC.

HANS BISHOP, CATHERINE FRIEDMAN, RICHARD GOOLD, ELIZABETH HOMANS, RICHARD KLAUSNER, ROBERT NELSON, NICHOLAS RESTIFO, STAN RIDDELL, MARGO ROBERTS, HEATHER TURNER

DIRECTOR

RESOLYS BIO, INC.

MCKAY BELK, JEFFREY A. ECKMANN, THOMAS HATCH, DAMIAN MARRON, JOHN MCMICHAEL, RICHARD SANDBERG, JAMES TOBIN

DIRECTOR

KRYGER EVENT FUND LP

STEVEN CLARK, PETER HEAPS, STEVEN HILL, - KRYGER EVENT GENERAL PARTNER LIMITED, - OMNI EVENT GENERAL PARTNER LIMITED, ALISON SIMPSON, GEORGE E. THOMAS

EXECUTIVE OFFICER

BOTANICA VENTURES LLC

STEPHEN S HILL, STEPHEN S. HILL

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

OTHER

DECLINE TO DISCLOSE

Equity

2025-09-19

D/A

HEDGE FUND

2016-08-01

D

BIOTECHNOLOGY

NO REVENUES

Equity

2023-06-07

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2022-10-24

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2020-03-05

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2019-08-29

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2019-03-05

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-07-09

D

OTHER ENERGY

$1 - $1,000,000

Equity

2013-08-01

D

OTHER ENERGY

$1 - $1,000,000

Equity

2012-06-01